JP2024521765A5 - - Google Patents

Info

Publication number
JP2024521765A5
JP2024521765A5 JP2023572709A JP2023572709A JP2024521765A5 JP 2024521765 A5 JP2024521765 A5 JP 2024521765A5 JP 2023572709 A JP2023572709 A JP 2023572709A JP 2023572709 A JP2023572709 A JP 2023572709A JP 2024521765 A5 JP2024521765 A5 JP 2024521765A5
Authority
JP
Japan
Application number
JP2023572709A
Other languages
Japanese (ja)
Other versions
JP2024521765A (ja
JPWO2022250731A5 (https=
Filing date
Publication date
Priority claimed from PCT/US2021/034334 external-priority patent/WO2021242913A1/en
Application filed filed Critical
Publication of JP2024521765A publication Critical patent/JP2024521765A/ja
Publication of JPWO2022250731A5 publication Critical patent/JPWO2022250731A5/ja
Publication of JP2024521765A5 publication Critical patent/JP2024521765A5/ja
Pending legal-status Critical Current

Links

JP2023572709A 2020-05-26 2021-12-01 勃起不全を治療するための製剤および方法 Pending JP2024521765A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US202063029881P 2020-05-26 2020-05-26
USPCT/US2021/034334 2021-05-26
PCT/US2021/034334 WO2021242913A1 (en) 2020-05-26 2021-05-26 Formulations and methods for treating erectile dysfunction
PCT/US2021/061488 WO2022250731A1 (en) 2020-05-26 2021-12-01 Formulations and methods for treating erectile dysfunction

Publications (3)

Publication Number Publication Date
JP2024521765A JP2024521765A (ja) 2024-06-04
JPWO2022250731A5 JPWO2022250731A5 (https=) 2024-12-10
JP2024521765A5 true JP2024521765A5 (https=) 2024-12-10

Family

ID=78722740

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023572709A Pending JP2024521765A (ja) 2020-05-26 2021-12-01 勃起不全を治療するための製剤および方法

Country Status (10)

Country Link
US (1) US20240216383A1 (https=)
EP (1) EP4157449A4 (https=)
JP (1) JP2024521765A (https=)
KR (1) KR20240013128A (https=)
CN (1) CN116568289A (https=)
AU (1) AU2021280285A1 (https=)
BR (1) BR112022024098A2 (https=)
CA (1) CA3179630A1 (https=)
IL (1) IL298432A (https=)
WO (2) WO2021242913A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL247528B1 (pl) * 2023-04-08 2025-07-21 Sativa Med Spolka Akcyjna Płynna kompozycja inhibitorów fosfodiesterazy typu 5 (PDE-5), sposób jej wytwarzania oraz jej zastosowanie do leczenia zaburzeń erekcji

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2391968A1 (en) * 1999-11-18 2001-05-25 Natco Pharma Limited An improved pharmaceutical composition for treating male erectile dysfunction
DE10118306A1 (de) * 2001-04-12 2002-10-17 Bayer Ag Imidazotriazinonhaltige Zusammensetzungen zur nasalen Applikation
DE102004023069A1 (de) * 2004-05-11 2005-12-08 Bayer Healthcare Ag Neue Darreichungsformen des PDE 5-Inhibitors Vardenafil
US20060051413A1 (en) * 2004-09-08 2006-03-09 Chow Sing S M Method of enhancing absorptions of transmucosal administration formulations
DE102005009240A1 (de) * 2005-03-01 2006-09-07 Bayer Healthcare Ag Arzneiformen mit verbesserten pharmakokinetischen Eigenschaften
DE102005009241A1 (de) * 2005-03-01 2006-09-07 Bayer Healthcare Ag Arzneiformen mit kontrollierter Bioverfügbarkeit
US20060207596A1 (en) * 2005-03-18 2006-09-21 Fairfield Clinical Trials, Llc Device and method for delivery of combination nasal medication
US8911751B2 (en) * 2005-10-11 2014-12-16 Yissum Research Development Company Of The Hebrew University Of Jerusalem Compositions for nasal delivery
MX2010004265A (es) * 2007-10-19 2010-07-28 Innozen Inc Composicion para administrar un ingrediente activo y metodo para hacer y usar el mismo.
GB2497933B (en) * 2011-12-21 2014-12-24 Londonpharma Ltd Drug delivery technology
US20140271847A1 (en) * 2013-03-13 2014-09-18 SatisPharma, LLC Formulations and methods for rapid penile erections
US20170014417A1 (en) * 2015-07-14 2017-01-19 Lipp Life Sciences Llc Pharmaceutical administration system for the transdermal application of vardenafil
CN111655229A (zh) * 2017-12-20 2020-09-11 卡里亚制药控股有限公司 包含伐地那非的薄膜制剂、其制备方法及其用途
US11648197B2 (en) * 2018-06-28 2023-05-16 Arx, Llc Dispensing method for producing dissolvable unit dose film constructs

Similar Documents

Publication Publication Date Title
JP2024521765A5 (https=)
CN305751799S (https=)
CN305757450S (https=)
CN305602719S (https=)
CN305604889S (https=)
CN305605060S (https=)
CN305605641S (https=)
CN305607236S (https=)
CN305634557S (https=)
CN305641813S (https=)
CN305651213S (https=)
CN305652673S (https=)
CN305652845S (https=)
CN305654008S (https=)
CN305655874S (https=)
CN305659116S (https=)
CN305659511S (https=)
CN305660577S (https=)
CN305661953S (https=)
CN305662246S (https=)
CN305662686S (https=)
CN305663488S (https=)
CN305668484S (https=)
CN305668972S (https=)
CN305712657S (https=)